Posted in

News

Dr. Fahd Qadir, Ph.D., joins the UFDI!

Please join us in welcoming Dr. Fahd Qadir, Ph.D., to the University of Florida Diabetes Institute as a tenure-track Assistant Professor in the Department of Pathology, Immunology and Laboratory Medicine! Dr. Qadir’s lab investigates how pancreatic β-cells maintain mitochondrial resilience during metabolic and inflammatory stress, and how these…

Glycogen drives the sensory activation of POMC neurons

Congratulations to Dr. Matthew Gentry and collaborators on their latest publication in Nature Metabolism! Their study shows that brain glycogen plays an active role in regulating POMC neurons, which are crucial cells involved in appetite and energy balance. By offering new insight into how the brain senses fuel…

Breakthroughs begin here: Revolutionizing diabetes research

Exciting research out of the University of Florida is transforming how we understand and treat diabetes. Scientists at UF Health are making major strides in uncovering the biology behind the disease, with innovative approaches that could reshape the future of care by targeting the root causes of diabetes…

Dr. Brittany Bruggeman MD Newsline Interview

We’re pleased to share this interview featuring UFDI’s Dr. Brittany Bruggeman, who discusses her research on fecal elastase as a potential early biomarker for type 1 diabetes, recorded at ADA 2026.

Ashby Walker, Ph.D., guest editor on the special edition of The Journal of Diabetes Research, “Interventions to Promote Technology Equity in Diabetes Care”

Congratulations to Ashby Walker, Ph.D., on guest editing the special edition of The Journal of Diabetes Research, “Interventions to Promote Technology Equity in Diabetes Care,” now fully available online. This special issue highlights innovative research aimed at advancing equitable access to diabetes technology and includes contributions from several…

Michael Haller elected Chairman of Type 1 Diabetes TrialNet

Congratulations to Michael Haller on being elected Chairman of Type 1 Diabetes TrialNet! This appointment recognizes Dr. Haller’s leadership and longstanding commitment to advancing research for the prediction, prevention, and treatment of Type 1 Diabetes. As Chair of TrialNet, Dr. Haller will help guide one of the world’s…